JB
Joel Beatty Baird Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Leap Therapeutics
LPTX
$11.7M
| $0.2824 | $9 |
3,087%
upside
| Outperform |
19 Mar ‘24
1 year ago |
|
27
Syndax Pharmaceuticals
SNDX
$1.37B
| $15.93 | $28 |
76%
upside
| Outperform |
3 Oct ‘23
1 year ago |
|
28
INmune Bio
INMB
$47.3M
| $1.78 | $16 |
799%
upside
| Outperform |
1 Jun ‘23
2 years ago |
|
29
BeyondSpring
BYSI
$78.2M
| $1.94 | $1.25 |
36%
downside
| Outperform |
2 May ‘23
2 years ago |
|
30
Pliant Therapeutics
PLRX
$107M
| $1.75 | $44 |
2,414%
upside
| Outperform |
13 Apr ‘23
2 years ago |
|
31
Arrowhead Research
ARWR
$3.83B
| $27.73 | $58 |
109%
upside
| Outperform |
7 Feb ‘23
2 years ago |
|
32
IDEAYA Biosciences
IDYA
$2.17B
| $24.74 | $24 |
3%
downside
| Outperform |
18 Nov ‘22
2 years ago |
|
33
Arcturus Therapeutics
ARCT
$487M
| $17.94 | $18 |
0%
upside
| Underperform |
10 Nov ‘22
2 years ago |
|
34
Cardiff Oncology
CRDF
$142M
| $2.13 | $6 |
182%
upside
| Outperform |
29 Aug ‘22
3 years ago |
|
35
Vir Biotechnology
VIR
$728M
| $5.24 | $28 |
434%
upside
| Neutral |
3 Mar ‘22
3 years ago |
|
|
36
Pliant Therapeutics
PLRX
$107M
| $1.75 | $52 |
2,871%
upside
| Buy |
5 Apr ‘21
4 years ago |
|
37
Alnylam Pharmaceuticals
ALNY
$63.2B
| $482.13 | $175 |
64%
downside
| Neutral |
12 Feb ‘21
4 years ago |
|
38
Vanda Pharmaceuticals
VNDA
$266M
| $4.51 | $14 |
210%
upside
| Neutral |
14 Jan ‘21
4 years ago |
|
39
Sarepta Therapeutics
SRPT
$1.85B
| $17.64 | $108 |
512%
upside
| Neutral |
12 Jan ‘21
4 years ago |
|
40
PTC Therapeutics
PTCT
$4.64B
| $58.42 | $85 |
46%
upside
| Buy |
5 Jan ‘21
4 years ago |
|
41
Ionis Pharmaceuticals
IONS
$10.3B
| $64.40 | $78 |
21%
upside
| Buy |
10 Aug ‘20
5 years ago |
|
42
Tempest Therapeutics
TPST
$48.8M
| $11 | $90 |
718%
upside
| Buy |
29 May ‘20
5 years ago |
|
|
DBVT
43
DBV Technologies
DBVT
$257M
| $9.40 | $100 |
964%
upside
| Buy |
6 Apr ‘20
5 years ago |
|
|
AMRN
44
Amarin Corp
AMRN
$315M
| $15.22 | $120 |
688%
upside
| Buy |
1 Apr ‘20
5 years ago |
|
45
X4 Pharmaceuticals
XFOR
$73.6M
| $3.28 | $450 |
13,620%
upside
| Buy |
26 Mar ‘20
5 years ago |
|